The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A protocol for pretreatment testing for antibodies to galactose-alpha-1,3-galactose to mitigate the risk of cetuximab hypersensitivity reactions.
 
Nicholas Della Marta
No Relationships to Disclose
 
Alexander Yuile
Consulting or Advisory Role - Merck
 
Claire Mok
No Relationships to Disclose
 
Joe Wei
No Relationships to Disclose
 
Meredith Oatley
No Relationships to Disclose
 
Tracey Skinner
No Relationships to Disclose
 
Samuel Miller
No Relationships to Disclose
 
Sheryl van Nunen
No Relationships to Disclose
 
Stephen Clarke
Employment - GenesisCare
Stock and Other Ownership Interests - GenesisCare
Honoraria - Tetra Health
Consulting or Advisory Role - AllVascular; AstraZeneca/MedImmune; AstraZeneca/MedImmune; Bayer; Ipsen; Merck
Speakers' Bureau - Merck; Novartis/Ipsen
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MedLab
 
Connie Diakos
Employment - Genesis Cancer Care
Stock and Other Ownership Interests - Genesis Cancer Care
Honoraria - Amgen; Merck; Merck; Pfizer
Consulting or Advisory Role - Amgen; Ipsen; Ipsen
Speakers' Bureau - The Limbic
Travel, Accommodations, Expenses - GlaxoSmithKline; GlaxoSmithKline; Ipsen
 
Madhawa De Silva
No Relationships to Disclose
 
David Chan
Honoraria - Ipsen; Novartis
Travel, Accommodations, Expenses - Ipsen; Novartis
 
Gavin Marx
No Relationships to Disclose
 
Nick Pavlakis
Honoraria - Bayer; BeiGene; BeiGene; Pierre Fabre; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Beigene; Boehringer Ingelheim; Bristol-Myers Squibb; Duo Oncology; Gilead Sciences; Janssen Oncology; Merck KGaA; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Takeda
Speakers' Bureau - Merck KGaA
Research Funding - Bayer (Inst); Pfizer (Inst); Roche (Inst)